Drug R&D May Depend On Govt. Funds If Price Disparities Persist – Crawford
Drug price controls in the international market could lead to a reliance on government funds for pharmaceutical R&D, FDA Acting Commissioner Lester Crawford said
You may also be interested in...
The debate over drug importation highlights the need for reduced drug prices, Centers for Medicare & Medicaid Services Administrator Mark McClellan said Aug. 30
Illinois will contract with a non-domestic PBM to administer personal drug reimportation from Ireland, the United Kingdom and Canada
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3